1. Unit for Genomics in Myeloma, Institut Universitaire du Cancer de Toulouse-Oncopole, University Hospital, Toulouse, France;
2. Centre de Recherche en Cancérologie de Toulouse, INSERM U1037, Toulouse, France;
3. Department of Hematology, Institut Universitaire du Cancer de Toulouse-Oncopole, University Hospital, Toulouse, France;
4. Department of Hematology, University Hospital, Dijon, France;
5. Department of Hematology, University Hospital, Creteil, France;
6. Department of Hematology, University Hospital, Bordeaux, France;
7. Department of Hematology, University Hospital, Poitiers, France;
8. Hematology and Cellular Therapy Department, Saint-Antoine University Hospital, Sorbonne University, and INSERM UMRs 938, Paris, France;
9. Department of Hematology, University Hospital, Lille, France;
10. Department of Hematology, Departmental Hospital, Annecy, France;
11. Department of Hematology, Departmental Hospital, Chalon, France;
12. Department of Hematology, University Hospital, Limoges, France;
13. Department of Hematology, University Hospital, Lyon, France;
14. Department of Hematology, University Hospital, Caen, France;
15. Department of Hematology, University Hospital, Bobigny, France;
16. Department of Hematology, University Hospital, Angers, France;
17. Department of Hematology, Departmental Hospital, Perpignan, France;
18. Department of Hematology, University Hospital, Besancon, France;
19. Department of Hematology, University Hospital, Nancy, France;
20. Department of Hematology, University Hospital, Amiens, France;
21. INSERM U892, University of Nantes, Nantes, France; and
22. Department of Hematology, University Hospital, Nantes, France